Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenue (see Note 8 for related party transactions) $ 6,309 $ 5,492
Cost of revenue (see Note 8 for related party transactions) 8,306 6,696
Gross loss (1,997) (1,204)
Operating Expenses    
General and Administrative Expense 10,149 7,662
Selling and Marketing Expense 5,724 1,489
Research and Development Expense 14,748 20,343
Total operating expenses 30,621 29,494
Loss from operations (32,618) (30,698)
Other income (expense):    
Interest income, net 111 7
Change in fair value of derivative liabilities (3,990) 7,183
Other expense, net 10 (48)
Net loss before income taxes (36,487) (23,556)
Income tax 2 10
Net loss (36,489) (23,566)
Other comprehensive loss:    
Net foreign currency translation adjustments 0 (7)
Total Comprehensive loss $ (36,489) $ (23,573)
Basic - Weighted average shares outstanding 241,599,990 231,990,998
Diluted - Weighted average shares outstanding 241,599,990 231,990,998
Class A and C Common Stock    
Other comprehensive loss:    
Earnings Per Share, Basic $ (0.15) $ (0.10)
Earnings Per Share, Diluted $ (0.15) $ (0.10)